Giordano Christopher Thomas, CEO of Tenax Therapeutics ($TENX), made three open market purchases totaling about $20,000 in the last year. His most recent buy was on November 20, 2025. These purchases rank 3,832nd among nearly 5,000 insiders, where the average is $1.5 million across about 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | TENAX THERAPEUTICS, INC. | $TENX | Giordano Christopher Thomas | CEO | A | Stock Option (right to buy) | 450000 | $0.00 | 3,100,719.0000 | 39,741,404 | 16.98% | 1.13% |
| Nov. 18, 2025 | TENAX THERAPEUTICS, INC. | $TENX | Giordano Christopher Thomas | CEO | P | Common Stock | 1612 | $7.75 | 1,612.0000 | 39,741,404 | 9999.99% | 0.00% |
| Nov. 19, 2025 | TENAX THERAPEUTICS, INC. | $TENX | Giordano Christopher Thomas | CEO | P | Common Stock | 455 | $7.51 | 2,067.0000 | 39,741,404 | 28.23% | 0.00% |
| Nov. 20, 2025 | TENAX THERAPEUTICS, INC. | $TENX | Giordano Christopher Thomas | CEO | P | Common Stock | 538 | $7.59 | 2,605.0000 | 39,741,404 | 26.03% | 0.00% |
| May 16, 2025 | TENAX THERAPEUTICS, INC. | $TENX | Giordano Christopher Thomas | CEO | A | Stock Option (right to buy) | 1400000 | $0.00 | 2,650,719.0000 | 15,271,705 | 111.94% | 9.17% |
| Dec. 10, 2024 | TENAX THERAPEUTICS, INC. | $TENX | Giordano Christopher Thomas | CEO | A | Stock Option (right to buy) | 1250000 | $0.00 | 1,250,719.0000 | 21,161,143 | 9999.99% | 5.91% |
| May 17, 2024 | TENAX THERAPEUTICS, INC. | $TENX | Giordano Christopher Thomas | CEO | A | Stock Option (right to buy) | 437 | $0.00 | 719.0000 | 248,447 | 154.96% | 0.18% |